Showing results (141-150 of 254) with videos related to

Sort By:
Pageof 26
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2014
Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective studyMike van der Have, Tim D G Belderbos, Herma H Fidder, et al.
Inflammatory Bowel Diseases|January 31, 2007
Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levelsHans Blokzijl, Sara Vander Borght, Lisette I H Bok, et al.
Alimentary Pharmacology & Therapeutics|July 12, 2024
Clinical trial: The effectiveness of long-acting somatostatin analogue for output reduction of high-output intestinal fistula or small bowel enterostomy. A randomised controlled trialAllard S Timmer, Fleur de Vries, Sarah L Gans, et al.
Scandinavian Journal of Gastroenterology|February 9, 2011
Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The NetherlandsJudith E Baars, Ernst J Kuipers, Gerard Dijkstra, et al.
Therapeutic Advances in Gastroenterology|May 17, 2021
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment optionsArno R Bourgonje, Reinier C A van Linschoten, Rachel L West, et al.
International Journal of Molecular Sciences|July 28, 2022
Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's DiseaseMarta S Alexdottir, Arno R Bourgonje, Morten A Karsdal, et al.
Gastroenterology|September 22, 2010
Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's diseaseAngela E Oostlander, Nathalie Bravenboer, Evelien Sohl, et al.
Frontiers in Immunology|July 22, 2022
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel DiseaseAntonius T Otten, Arno R Bourgonje, Petra P Horinga, et al.
Frontiers in Medicine|July 29, 2022
Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn's DiseaseMarta S Alexdottir, Arno R Bourgonje, Morten A Karsdal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2013
Adalimumab and infliximab are equally effective for Crohn's disease in patients not previously treated with anti-tumor necrosis factor-α agentsChristine Kestens, Martijn G H van Oijen, Charlotte L J Mulder, et al.
Pageof 26